{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:03:39Z","timestamp":1761991419508,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803592"],"award-info":[{"award-number":["81803592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jgar.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T02:47:52Z","timestamp":1668480472000},"page":"371-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids"],"prefix":"10.1016","volume":"31","author":[{"given":"Jin","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-0252","authenticated-orcid":false,"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-3258","authenticated-orcid":false,"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.11.006_bib0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.jgar.2022.11.006_bib0002","article-title":"Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb","volume":"5","author":"Zoulim","year":"2015","journal-title":"Perspect Med"},{"key":"10.1016\/j.jgar.2022.11.006_bib0003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev-virology-091919-062728","article-title":"Prospects for the global elimination of hepatitis B","volume":"8","author":"Block","year":"2021","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/3987","article-title":"Evidence for a newly discovered cellular anti-HIV-1 phenotype","volume":"4","author":"Simon","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jgar.2022.11.006_bib0006","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2022.11.006_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2022.11.006_bib0008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2022.11.006_bib0009","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jgar.2022.11.006_bib0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/hep.20580","article-title":"G to A hypermutation of hepatitis B virus","volume":"41","author":"Noguchi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jgar.2022.11.006_bib0011","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1073\/pnas.0408223102","article-title":"Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo","volume":"102","author":"Suspene","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jgar.2022.11.006_bib0012","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3748\/wjg.v12.i28.4492","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo","volume":"12","author":"Lei","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0013","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.02510-06","article-title":"Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G","volume":"81","author":"Nguyen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0014","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1128\/JVI.00465-08","article-title":"Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids","volume":"82","author":"Nguyen","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003361","article-title":"Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA","volume":"9","author":"Kitamura","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.11.006_bib0016","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/jvh.12110","article-title":"Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B","volume":"20","author":"Beggel","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jgar.2022.11.006_bib0017","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.79.13.8079-8089.2005","article-title":"Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells","volume":"79","author":"Machida","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10735-006-9059-0","article-title":"High expression of APOBEC3G in patients infected with hepatitis C virus","volume":"37","author":"Komohara","year":"2006","journal-title":"J Mol Histol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0019","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1099\/vir.0.038919-0","article-title":"The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses","volume":"93","author":"Fehrholz","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0020","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1093\/nar\/gky840","article-title":"Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0021","article-title":"Host restriction factor A3G inhibits the replication of Enterovirus D68 through competitively binding 5\u2032 UTR with PCBP1","volume":"96","author":"Li","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0022","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1496","article-title":"Small-molecule inhibition of HIV-1 Vif","volume":"26","author":"Nathans","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0023","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.M109.085308","article-title":"Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G","volume":"285","author":"Cen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jgar.2022.11.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126638","article-title":"Design, synthesis, and biological evaluation of 2-amino-N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif inhibitors","volume":"29","author":"Zhang","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jgar.2022.11.006_bib0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2015.07.009","article-title":"Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex","volume":"122","author":"Zhang","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0026","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1743-422X-11-122","article-title":"Small molecules that inhibit Vif-induced degradation of APOBEC3G","volume":"11","author":"Matsui","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.jgar.2022.11.006_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.03.005","article-title":"APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity","volume":"165","author":"Wang","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0028","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007742","article-title":"DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA","volume":"15","author":"Tang","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.11.006_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.09.001","article-title":"CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: implications for mechanism of inhibiting pgRNA packaging","volume":"159","author":"Wu","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006658","article-title":"HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways","volume":"13","author":"Guo","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.11.006_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA Topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA","volume":"93","author":"Sheraz","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.jgar.2022.11.006_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2019.08.003","article-title":"Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus","volume":"518","author":"Kanagaraj","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jgar.2022.11.006_bib0034","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2017.11.006","article-title":"APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription","volume":"149","author":"Chen","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1179\/joc.2008.20.4.458","article-title":"Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly","volume":"20","author":"Wu","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2022.11.006_bib0036","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jgar.2022.11.006_bib0037","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virusres.2010.05.009","article-title":"APOBEC3G directly binds hepatitis B virus core protein in cell and cell free systems","volume":"151","author":"Zhao","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.jgar.2022.11.006_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000928","article-title":"Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis","volume":"6","author":"Vartanian","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.11.006_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008718","article-title":"Footprint of the host restriction factors APOBEC3 on the genome of human viruses","volume":"16","author":"Poulain","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jgar.2022.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fmicb.2020.01653","article-title":"Differences in HBV replication, APOBEC3 family expression, and inflammatory cytokine levels between wild-type HBV and pre-core (G1896A) or basal core promoter (A1762T\/G1764A) mutants","volume":"11","author":"Lau","year":"2020","journal-title":"Front Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522002508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:00:44Z","timestamp":1761991244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522002508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"alternative-id":["S2213716522002508"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.11.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}